NCT06936579

Brief Summary

Through motor muscle potentials, we will observe how a peripheral somatosensory mechanical stimulus on key limb musculature communicates signals via afferent sensory fibers that encode proprioceptive signals from muscle spindles (particularly type Ia fibers) to the somatosensory cortex at rest, confirming the integrative hypothesis of movement. These results would support interventions aimed at addressing sensory deafferentation present in multiple health conditions related to movement disorders, where disuse or immobilization lead to changes in movement patterns and a decrease in neuronal activation in somatosensory cortex areas involved in constructing voluntary movement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

May 20, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
Last Updated

April 24, 2025

Status Verified

April 1, 2025

Enrollment Period

2 months

First QC Date

April 12, 2025

Last Update Submit

April 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Motor evoked potentials (MEPs)

    transcranial magnetic stimulation (TMS)

    45 minuts

Study Arms (3)

Condition without proprioceptive stimulation:

NO INTERVENTION

Participants will not receive the stimulus, and MEP activity will be recorded under the same motor cortex stimulation conditions.

Condition with proprioceptive stimulation 1

EXPERIMENTAL

Participants will receive proprioceptive stimulation through the output plunger, applied continuously for 15 seconds, with 20-second rest intervals, over a total duration of 5 minutes. MEP activity will then be recorded via motor cortex stimulation.

Device: proprioceptive stimulation

Condition with proprioceptive stimulation 2

ACTIVE COMPARATOR

Participants will receive proprioceptive stimulation continuously during the application of TMS pulses while MEP activity is recorded.

Device: proprioceptive stimulation

Interventions

Condition without proprioceptive stimulation: Participants will not receive the stimulus, and MEP activity will be recorded under the same motor cortex stimulation conditions. Condition with proprioceptive stimulation 1: Participants will receive proprioceptive stimulation through the output plunger, applied continuously for 15 seconds, with 20-second rest intervals, over a total duration of 5 minutes. MEP activity will then be recorded via motor cortex stimulation. Condition with proprioceptive stimulation 2: Participants will receive proprioceptive stimulation continuously during the application of TMS pulses while MEP activity is recorded.

Condition with proprioceptive stimulation 1Condition with proprioceptive stimulation 2

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Good health status with no history of neuromuscular injuries, surgical interventions, or trauma affecting the central or peripheral nervous system.
  • Not currently taking drugs or medications known to affect the central nervous system, and not pregnant at the time of testing.
  • No metallic or electronic implants and no history of epilepsy.
  • (Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pedro Victor López Plaza

Barcelona, Spain

Location

Central Study Contacts

Pedro V López Plaza

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Each participant will serve as their own control and will be assessed under both stimulation (experimental) and no-stimulation (control) conditions
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator,

Study Record Dates

First Submitted

April 12, 2025

First Posted

April 20, 2025

Study Start

May 20, 2025

Primary Completion

July 15, 2025

Study Completion

July 30, 2025

Last Updated

April 24, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations